Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03014297
Recruitment Status : Terminated (Part I completed. Part 2 will not be done due to sponsor decision.)
First Posted : January 9, 2017
Last Update Posted : August 8, 2019
Information provided by (Responsible Party):
Lowell Anthony, MD, University of Kentucky

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 5, 2018
Actual Study Completion Date : November 16, 2018